SLC6A3 and Alzheimer disease: The utility of DAT imaging in distinguishing DLB from AD is well-established, with sensitivity (78%) and specificity (90%).26Figure 1 shows 123iodine FP-CIT SPECT images in patients with AD, patients with DLB, and normal controls.